Search Results - "Phillips, Joseph D"

Refine Results
  1. 1
  2. 2

    The significant role of mast cells in cancer by Khazaie, Khashayarsha, Blatner, Nichole R., Khan, Mohammad Wasim, Gounari, Fotini, Gounaris, Elias, Dennis, Kristen, Bonertz, Andreas, Tsai, Fu-Nien, Strouch, Matthew J., Cheon, Eric, Phillips, Joseph D., Beckhove, Philipp, Bentrem, David J.

    Published in Cancer and metastasis reviews (01-03-2011)
    “…Mast cells (MC) are a bone marrow-derived, long-lived, heterogeneous cellular population that function both as positive and negative regulators of immune…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    The Effect of Lung Resection for NSCLC on Circulating Immune Cells: A Pilot Study by Phillips, Joseph D, Fay, Kayla A, Bergeron, Alan J, Zhang, Peisheng, Mielcarz, Daniel W, Calkins, Andrew M, Searles, Tyler G, Christensen, Brock C, Finley, David J, Turk, Mary Jo, Channon, Jacqueline Y

    Published in Current oncology (Toronto) (17-05-2023)
    “…This pilot study sought to evaluate the circulating levels of immune cells, particularly regulatory T-cell (Treg) subsets, before and after lung resection for…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Preferential expansion of pro-inflammatory Tregs in human non-small cell lung cancer by Phillips, Joseph D., Knab, Lawrence M., Blatner, Nichole R., Haghi, Leila, DeCamp, Malcolm M., Meyerson, Shari L., Heiferman, Michael J., Heiferman, Jeffrey R., Gounari, Fotini, Bentrem, David J., Khazaie, Khashayarsha

    Published in Cancer Immunology, Immunotherapy (01-09-2015)
    “…Objectives Lung cancer is the leading cause of cancer-related death in the USA. Regulatory T cells (Tregs) normally function to temper immune responses and…”
    Get full text
    Journal Article
  8. 8

    Factors Affecting Selection of Operative Approach and Subsequent Short-Term Outcomes after Anatomic Resection for Lung Cancer by Phillips, Joseph D., MD, Merkow, Ryan P., MD, Sherman, Karen L., MD, DeCamp, Malcolm M., MD, FACS, Bentrem, David J., MD, MS, FACS, Bilimoria, Karl Y., MD, MS

    “…Background Previous studies evaluating video-assisted thoracoscopic surgery (VATS) for lung cancer are single-institution series, suffer from small sample…”
    Get full text
    Journal Article
  9. 9

    Impact of neuroimaging in the pretreatment evaluation of early stage non-small cell lung cancer by Wasp, Garrett T., Del Prete, Christopher, Farrell, Jonathan A.D., Dragnev, Konstantin H., Russo, Gregory, Atkins, Graham T., Phillips, Joseph D., Brooks, Gabriel A.

    Published in Heliyon (01-06-2020)
    “…There are limited data and conflicting guideline recommendations regarding the role of neuroimaging in the pretreatment evaluation of non-small cell lung…”
    Get full text
    Journal Article
  10. 10

    Needs Assessment for an Errors-Based Curriculum on Thoracoscopic Lobectomy by Meyerson, Shari L., MD, Tong, Betty C., MD, Balderson, Stafford S., PA-C, D'Amico, Thomas A., MD, Phillips, Joseph D., MD, DeCamp, Malcolm M., MD, DaRosa, Debra A., PhD

    Published in The Annals of thoracic surgery (01-08-2012)
    “…Background Research suggests a benefit from a skills curriculum emphasizing error prevention, identification, and management. Our purpose was to identify…”
    Get full text
    Journal Article
  11. 11

    Patient-Reported Outcomes in Surgical Oncology: An Overview of Instruments and Scores by Phillips, Joseph D., Wong, Sandra L.

    Published in Annals of surgical oncology (01-01-2020)
    “…Traditional measures of quality and effectiveness in surgical oncology have focused on morbidity, mortality, and when available, recurrence rates. Measuring…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non–small cell lung cancer by Tong, Betty C., Gu, Lin, Wang, Xiaofei, Wigle, Dennis A., Phillips, Joseph D., Harpole, David H., Klapper, Jacob A., Sporn, Thomas, Ready, Neal E., D'Amico, Thomas A.

    “…Pembrolizumab is a programmed death receptor-1 masking antibody approved for metastatic non–small cell lung cancer. This Phase 2 study (NCT02818920) of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Knowing the Bad: Adverse Event-Informed, High-Risk, Early-Stage Non-Small Cell Lung Cancer Treatment Options by Phillips, Joseph D

    Published in Annals of the American Thoracic Society (01-12-2022)
    “…Phillips discusses the study by Wang et al which compares adverse events (AEs) after limited resection and stereotactic body radiation therapy (SBRT) for…”
    Get full text
    Journal Article
  16. 16

    Laparoscopic Gastrectomy for Cancer by Phillips, Joseph D., MD, Nagle, Alexander P., MD, Soper, Nathaniel J., MD

    “…Gastric cancer is common worldwide. Tumor location and disease stage differ between Asian and Western countries. Western patients often have higher BMIs and…”
    Get full text
    Journal Article
  17. 17

    Disparities in Access to Multidisciplinary Cancer Consultations and Treatment for Patients With Early-Stage Non-Small Cell Lung Cancer: A SEER-Medicare Analysis by Liu, You-Chi, Schmidt, Rachel O., Kapadia, Nirav S., Phillips, Joseph D., Moen, Erika L.

    “…Disparities in access to a multidisciplinary cancer consultation (MDCc) persist, and the role of physician relationships remains understudied. This study…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Surgical management of colorectal lung metastases by Phillips, Joseph D., Hasson, Rian M.

    Published in Journal of surgical oncology (01-04-2019)
    “…Pulmonary metastasectomy for colorectal cancer is an established means of treatment for select patients. This article will highlight the recent evidence…”
    Get full text
    Journal Article